Based on these findings, we speculate that GOT1, LDHB, and GPX3 may affect BC through the same mechanisms as those mentioned above, such as disrupting glycolysis and nucleotide metabolism, promoting ferroptosis, or downregulating the oxidant-regulated tumor-promoting signaling pathway. Here, GPX3 is linked to breast cancer.